Who is the CEO of INMB? | Glauxie AI

Q: Who is the CEO of INMB?

INmune Bio, Inc. (INMB) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO David J. Moss. INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product... Employees: 2,000.

Q: What does INMB company do?

Learn what INMB does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling INMB?

Track recent insider buys and sells for INMB with transaction details, amounts, and trends.

Q: What sector is INMB in?

Find INMB sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of INMB?

🦉

INmune Bio, Inc. (INMB)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEODavid J. Moss

INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its...

Key Executives

Name	Title
Cory Randall Ellspermann	Interim Chief Financial Officer
Daniel Frederick Carlson	Head of Investor Relations
David J. Moss	President, Chief Executive Officer, Treasurer, Secretary & Director
Joshua S. Schoonover	General Counsel
Mark William Lowdell	Chief Scientific Officer & Chief Manufacturing Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

INMB Profile Financials

What does INMB company do? Are insiders buying or selling INMB? What sector is INMB in?